Experience the OCT difference.
Request your Abbott Sales rep today.
OCTIVUS trial is an investigator-initiated, prospective, multicenter trial.
Composite of death from cardiac cause (TV-MI or ID-TVR at one year, powered for non-inferiority of the OCT group as compared with the IVUS group)
Watch Drs. J. Daemen (Rotterdam, NL) and Z. Ali (NY, USA) share their experiences using intravascular imaging technologies in this debate presented at the European Society of Cardiology (ESC) 2023.
You are about to enter an Abbott country- or region-specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions
Do you wish to continue and enter this website?